MetaADEDB 2.0 @ LMMD
distigmine
(GJHSNEVFXQVOHR-UHFFFAOYSA-L)
Structure
SMILES
C[n+]1cccc(c1)OC(=O)N(CCCCCCN(C(=O)Oc1ccc[n+](c1)C)C)C.[Br-].[Br-]
Molecular Formula:
C22H32Br2N4O4
Molecular Weight:
576.322
Log P:
-3.5346
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
0
TPSA:
66.84
CAS Number(s):
15876-67-2
Synonym(s)
1.
distigmine
2.
Ubretid
3.
distigmine bromide
4.
hexamarium
5.
pyridinium, 3,3'-(1,6-hexanediylbis((methylimino)carbonyl)oxy)bis-1-methyl-, dibromide
External Link(s)
MeSHC084645
PubChem Compound27522
ChEBI31512
CHEMBLCHEMBL1098285
KEGGdr:D01228
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Acute myocardial infarctionOFFSIDES
2Acute respiratory failureOFFSIDES
3AdenocarcinomaOFFSIDES
4Alanine Aminotransferase IncreasedOFFSIDES
5Altered state of consciousnessOFFSIDES
6Anal abscessOFFSIDES
7Anastomotic stenosisOFFSIDES
8ApneaOFFSIDES
9Aspiration PneumoniaOFFSIDES
10Atrial tachycardiaOFFSIDES
11B-lymphocyte count decreasedOFFSIDES
12Basophil percentage increasedOFFSIDES
13Benign Prostatic HyperplasiaOFFSIDES
14BicytopeniaOFFSIDES
15Blood albumin decreasedOFFSIDES
16Blood alkaline phosphatase increasedOFFSIDES
17Blood chloride decreasedOFFSIDES
18Blood creatine phosphokinase increasedOFFSIDES
19Blood lactate dehydrogenase increasedOFFSIDES
20Blood sodiumOFFSIDES
21Blood urea increasedOFFSIDES
22Blood urine presentOFFSIDES
23Cancer PainOFFSIDES
24Cerebral ventricle dilatationOFFSIDES
25DehydrationOFFSIDES
26Depressed Level of ConsciousnessOFFSIDES
27Diet refusalOFFSIDES
28DizzinessOFFSIDES
29Drug administered at inappropriate siteOFFSIDES
30Drug diversionOFFSIDES
31DysgeusiaOFFSIDES
32EczemaOFFSIDES
33Electroconvulsive TherapyOFFSIDES
34ErythemaOFFSIDES
35Flank PainOFFSIDES
36FormicationOFFSIDES
37Gamma-Glutamyltransferase IncreasedOFFSIDES
38Granulocyte count decreasedOFFSIDES
39HemicephalalgiaOFFSIDES
40HemiparesisOFFSIDES
41HemiplegiaOFFSIDES
42HypophagiaOFFSIDES
43HypoxiaOFFSIDES
44Incorrect drug dosage form administeredOFFSIDES
45Intentional drug misuseOFFSIDES
46Intercostal neuralgiaOFFSIDES
47Klebsiella sepsisOFFSIDES
48LeukoencephalopathyOFFSIDES
49Leukopenia neonatalOFFSIDES
50Liver carcinoma rupturedOFFSIDES
51Lymphocyte percentage decreasedOFFSIDES
52Multiple sclerosis relapseOFFSIDES
53Muscle WeaknessOFFSIDES
54MyelitisOFFSIDES
55NauseaOFFSIDES
56NocturiaOFFSIDES
57Oculomucocutaneous syndromeOFFSIDES
58Optic NeuritisOFFSIDES
59PemphigusOFFSIDES
60Perianal erythemaOFFSIDES
61Peripheral arterial occlusive diseaseOFFSIDES
62PneumothoraxOFFSIDES
63Prescribed overdoseOFFSIDES
64Psychiatric symptomOFFSIDES
65Pulmonary InfarctionOFFSIDES
66RhabdomyolysisOFFSIDES
67Sick Sinus SyndromeOFFSIDES
68Sinus bradycardiaOFFSIDES
69Sputum retentionOFFSIDES
70SyphilisOFFSIDES
71prostatitisOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.